The Impact of Pituitary-thyroid and Pituitary-adrenal Axes Function on COVID-19 Clinical Course.

The main focus of the study is the assessment of hormonal function in the course of COVID-19 infection with special regard for trends predicting clinical events defined as primary endpoints of the study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Adrenal Gland Diseases Adrenal Insufficiency Brain Diseases Central Nervous System Diseases Coronaviridae Infections Coronavirus Infections Endocrine System Diseases Euthyroid Sick Syndromes Hyperthyroidism Hypothalamic Diseases Hypothyroidism Infections Low Triiodothyronine Syndrome Lung Diseases Nervous System Diseases Nidovirales Infections Pituitary Diseases Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Subacute Thyroiditis Thyroid Diseases Thyroiditis Thyroiditis, Subacute Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

7 Szpital Marynarki Wojennej, Gdansk, Poland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

PCR-confirmed COVID-19 infection
volunteers consenting to participate

Exclusion criteria

no consent

Treatment and study plan

Primary outcomes

Meeting the primary endpoint criteria.

Time frame: Time of hospitalization, typically less than one month.

Primary endpoint is defined as a composite endpoint including death, mechanical ventilation, vasopressor use, noninvasive ventilation, prolonged hospital stay (>10 days).

Sponsors and collaborators

Lead sponsor

Medical University of Gdansk

Other

Collaborators

National Center for Research and Development, Poland

Registry information

Acronym: ENDO-COVID19

Important dates

Study start: 2021
Primary completion: 2021
Study completion: 2021
First posted: Oct 6, 2021
Registry last updated: Feb 24, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed